OrsoBio posts promising tirzepatide combo data

New findings suggest OrsoBio’s energy-burning approach could enhance tirzepatide’s effects while opening new possibilities for healthy aging. The next act after GLP-1s? US-based biopharma OrsoBio has a case. Obesity medicine has few unexpected transformations in recent years. Drugs such as tirzepatide have reshaped expectations around weight loss, helping millions of people achieve results once thought […] The post OrsoBio posts promising tirzepatide combo data appeared first on Longevity.Technology .

This story was reported by Longevity.Technology. EUROPES curates Europe's most relevant coverage — read the full report at the original source.

Read full coverage at Longevity.Technology →

OrsoBio posts promising tirzepatide combo data

More from Longevity

Mediterranean diet may activate tiny proteins that protect the heart and brain

Calico and Revel scientists reverse age-related protein damage

As life expectancy rises, talks start on a UN treaty to protect older persons

Elysium Health links NAD+ to menopause in new study

"Muscle is worth its weight in gold:" Life Time Experts Share Their Top Strength Training Tips for Women

SkinStylus secures new FDA win for healthier skin aging